Compare ELTK & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTK | ELUT |
|---|---|---|
| Founded | 1970 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.1M | 48.3M |
| IPO Year | 1998 | 2020 |
| Metric | ELTK | ELUT |
|---|---|---|
| Price | $9.20 | $1.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 8.1K | ★ 144.2K |
| Earning Date | 05-19-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | $16.18 | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | $48.71 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.30 | $0.50 |
| 52 Week High | $12.19 | $2.60 |
| Indicator | ELTK | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 65.01 | 58.79 |
| Support Level | $8.38 | $1.00 |
| Resistance Level | $9.37 | $1.18 |
| Average True Range (ATR) | 0.53 | 0.09 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 81.43 | 58.62 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.